Terms: = Leukemia AND MSI2, ENSG00000153944, 124540 AND Treatment
8 results:
1. Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
Zou D; Lv M; Chen Y; Niu T; Ma C; Shi C; Huang Z; Wu Y; Yang S; Wang Y; Wu N; Zhang Y; Ouyang G; Mu Q
Ann Hematol; 2024 Jan; 103(1):141-151. PubMed ID: 37749318
[TBL] [Abstract] [Full Text] [Related]
2. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract] [Full Text] [Related]
3. A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia.
Spinler K; Bajaj J; Ito T; Zimdahl B; Hamilton M; Ahmadi A; Koechlein CS; Lytle N; Kwon HY; Anower-E-Khuda F; Sun H; Blevins A; Weeks J; Kritzik M; Karlseder J; Ginsberg MH; Park PW; Esko JD; Reya T
Nat Commun; 2020 Nov; 11(1):5998. PubMed ID: 33243988
[TBL] [Abstract] [Full Text] [Related]
4. Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
Wang M; Sun XY; Zhou YC; Zhang KJ; Lu YZ; Liu J; Huang YC; Wang GZ; Jiang S; Zhou GB
Int J Oncol; 2020 May; 56(5):1274-1283. PubMed ID: 32319553
[TBL] [Abstract] [Full Text] [Related]
5. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.
Minuesa G; Albanese SK; Xie W; Kazansky Y; Worroll D; Chow A; Schurer A; Park SM; Rotsides CZ; Taggart J; Rizzi A; Naden LN; Chou T; Gourkanti S; Cappel D; Passarelli MC; Fairchild L; Adura C; Glickman JF; Schulman J; Famulare C; Patel M; Eibl JK; Ross GM; Bhattacharya S; Tan DS; Leslie CS; Beuming T; Patel DJ; Goldgur Y; Chodera JD; Kharas MG
Nat Commun; 2019 Jun; 10(1):2691. PubMed ID: 31217428
[TBL] [Abstract] [Full Text] [Related]
6. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract] [Full Text] [Related]
7. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract] [Full Text] [Related]
8. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.
Mu Q; Wang Y; Chen B; Qian W; Meng H; Tong H; Chen F; Ma Q; Ni W; Chen S; Jin J
Leuk Res; 2013 Aug; 37(8):922-7. PubMed ID: 23759245
[TBL] [Abstract] [Full Text] [Related]